ArticleJournal of Zhejiang University. Science. B2023

CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest.

Wen Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.